Clinical Study on the Use of Symbios Xenograft for Sinus Floor Elevation
Split-mouth Randomized Clinical Study on the Use of Symbios Xenograft for Sinus Floor Elevation
1 other identifier
interventional
10
1 country
1
Brief Summary
The study aims to evaluate the clinical and radiological behavior, the histological and morphometrical components, the expression of proteins related to bone formation, and the analysis of markers of reparative mesenchymal stromal cells, after using two different xenogenic biomaterials in combination with autogenous cortical bone for maxillary sinus floor elevation. A randomized split-mouth clinical study is designed to include patients in need of two-stage bilateral maxillary sinus floor elevation. Patients will be assigned to receive a mix of autogenous cortical bone (collected by a bone scraper from the access window to the maxillary sinus) and anorganic bovine bone (BioOss Xenograft) in one maxillary sinus or autogenous cortical bone and porcine bone mineral (Symbios Xenograft) in the other maxillary sinus. Cone-beam computerized tomography (CBCT) scans will be performed before and after sinus floor elevation and 6, 12 and 18 months after the procedure to assess the bone gain. Bone core biopsies will be obtained at the site of implant placement 6 months after the floor elevation. Histological sections will be subjected to histomorphometric and immunohistochemical evaluation of differentiation markers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 6, 2019
CompletedStudy Start
First participant enrolled
January 8, 2019
CompletedFirst Posted
Study publicly available on registry
January 9, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 2, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 27, 2022
CompletedMay 23, 2023
May 1, 2023
2.1 years
January 6, 2019
May 20, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sinus floor height change
CBCT scans will be performed after the sinus floor elevation and 6 months later before implant placement to calculate vertical bone height change
From surgery to 6 months
Secondary Outcomes (5)
Sinus floor height change after 12 months
From surgery to 12 months
Sinus floor height change after 18 months
From surgery to 18 months
Area of new mineralized tissue
6 months
Area of non-mineralized tissue
6 months
Area of remaining graft particles
6 months
Study Arms (2)
PBM+ACB
ACTIVE COMPARATORPorcine bone mineral (Symbios Xenograft) + autogenous cortical bone
ABB+ACB
EXPERIMENTALAnorganic bovine bone (BioOss Xenograft) + autogenous cortical bone
Interventions
Maxillary sinus floor elevation and bone grafting with the use of porcine bone mineral biomaterial (Symbios Xenograft) combined with autogenous cortical bone
Maxillary sinus floor elevation and bone grafting with the use of anorganic bovine bone biomaterial (BioOss Xenograft) combined with autogenous cortical bone
Eligibility Criteria
You may qualify if:
- Partially edentulous patients.
- Kennedy class I in the upper jaw.
- Less than 5 mm of residual crestal bone to the maxillary sinus.
- Need for the replacement of teeth with dental implants.
You may not qualify if:
- Sinus pathology (sinusitis, mucocele, cysts).
- Smokers.
- Previous long-term (\>3 months) use of drugs known to affect bone metabolism, such as bisphosphonates.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidad de Granada
Granada, 18071, Spain
Related Publications (3)
Galindo-Moreno P, de Buitrago JG, Padial-Molina M, Fernandez-Barbero JE, Ata-Ali J, O Valle F. Histopathological comparison of healing after maxillary sinus augmentation using xenograft mixed with autogenous bone versus allograft mixed with autogenous bone. Clin Oral Implants Res. 2018 Feb;29(2):192-201. doi: 10.1111/clr.13098. Epub 2017 Oct 26.
PMID: 29071736BACKGROUNDGalindo-Moreno P, Avila G, Fernandez-Barbero JE, Aguilar M, Sanchez-Fernandez E, Cutando A, Wang HL. Evaluation of sinus floor elevation using a composite bone graft mixture. Clin Oral Implants Res. 2007 Jun;18(3):376-82. doi: 10.1111/j.1600-0501.2007.01337.x. Epub 2007 Mar 12.
PMID: 17355356BACKGROUNDGalindo-Moreno P, Abril-Garcia D, Carrillo-Galvez AB, Zurita F, Martin-Morales N, O'Valle F, Padial-Molina M. Maxillary sinus floor augmentation comparing bovine versus porcine bone xenografts mixed with autogenous bone graft. A split-mouth randomized controlled trial. Clin Oral Implants Res. 2022 May;33(5):524-536. doi: 10.1111/clr.13912. Epub 2022 Mar 3.
PMID: 35224778RESULT
Study Officials
- PRINCIPAL INVESTIGATOR
Pablo Galindo-Moreno, DDS, MS, PhD
Universidad de Granada
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full Professor
Study Record Dates
First Submitted
January 6, 2019
First Posted
January 9, 2019
Study Start
January 8, 2019
Primary Completion
February 2, 2021
Study Completion
February 27, 2022
Last Updated
May 23, 2023
Record last verified: 2023-05